4SC-202 (resminostat)

resminostat · 4SC AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 4SC-202 (resminostat), covering 2015-04-01 to 2015-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS) [Phase 1]